Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis

World J Gastroenterol. 2018 Aug 28;24(32):3617-3625. doi: 10.3748/wjg.v24.i32.3617.

Abstract

Both Helicobacter pylori (H. pylori) infection and liver diseases, including nonalcoholic fatty liver disease (NAFLD), viral hepatitis, and hepatocellular carcinoma (HCC), have high prevalences worldwide, and the relationship between H. pylori infection and liver disease has been discussed for many years. Although positive correlations between H. pylori and NAFLD have been identified in some clinical and experimental studies, negative correlations have also been obtained in high-quality clinical studies. Associations between H. pylori and the pathogenesis of chronic viral hepatitis, mainly disease progression with fibrosis, have also been suggested in some clinical studies. Concerning HCC, a possible role for H. pylori in hepatocarcinogenesis has been identified since H. pylori genes have frequently been detected in resected HCC specimens. However, no study has revealed the direct involvement of H. pylori in promoting the development of HCC. Although findings regarding the correlations between H. pylori and liver disease pathogenesis have been accumulating, the existing data do not completely lead to an unequivocal conclusion. Further high-quality clinical and experimental analyses are necessary to evaluate the efficacy of H. pylori eradication in ameliorating the histopathological changes observed in each liver disease.

Keywords: Helicobacter pylori; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Viral hepatitis.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Carcinogenesis / pathology
  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / microbiology
  • Carcinoma, Hepatocellular / pathology*
  • Carcinoma, Hepatocellular / prevention & control
  • Disease Progression
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / epidemiology
  • Helicobacter Infections / pathology*
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / isolation & purification
  • Helicobacter pylori / pathogenicity*
  • Hepacivirus / isolation & purification
  • Hepatitis C, Chronic / epidemiology
  • Hepatitis C, Chronic / microbiology
  • Hepatitis C, Chronic / pathology*
  • Hepatitis C, Chronic / prevention & control
  • Humans
  • Liver / microbiology
  • Liver / pathology
  • Liver Cirrhosis / epidemiology
  • Liver Cirrhosis / microbiology
  • Liver Cirrhosis / pathology*
  • Liver Cirrhosis / prevention & control
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / microbiology
  • Liver Neoplasms / pathology*
  • Liver Neoplasms / prevention & control
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Non-alcoholic Fatty Liver Disease / microbiology
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / prevention & control
  • Prevalence
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents